2024-02-01 2025-01-31 false Capium Accounts Production 1.1 07500137 2024-02-01 2025-01-31 07500137 bus:AbridgedAccounts 2024-02-01 2025-01-31 07500137 bus:FRS102 2024-02-01 2025-01-31 07500137 bus:AuditExemptWithAccountantsReport 2024-02-01 2025-01-31 07500137 bus:SmallCompaniesRegimeForAccounts 2024-02-01 2025-01-31 07500137 bus:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 07500137 2024-02-01 2025-01-31 07500137 2025-01-31 07500137 bus:RegisteredOffice 2024-02-01 2025-01-31 07500137 core:WithinOneYear 2025-01-31 07500137 core:AfterOneYear 2025-01-31 07500137 1 2024-02-01 2025-01-31 07500137 bus:Director1 2024-02-01 2025-01-31 07500137 bus:Director1 2025-01-31 07500137 bus:Director1 2023-02-01 2024-01-31 07500137 2023-02-01 07500137 bus:LeadAgentIfApplicable 2024-02-01 2025-01-31 07500137 2023-02-01 2024-01-31 07500137 2024-01-31 07500137 core:WithinOneYear 2024-01-31 07500137 core:AfterOneYear 2024-01-31 07500137 bus:EntityAccountantsOrAuditors 2023-02-01 2024-01-31 07500137 bus:OrdinaryShareClass1 2024-02-01 2025-01-31 07500137 bus:OrdinaryShareClass1 2025-01-31 07500137 bus:OrdinaryShareClass1 2023-02-01 2024-01-31 07500137 bus:OrdinaryShareClass1 2024-01-31 07500137 core:ComputerEquipment 2024-02-01 2025-01-31 07500137 core:ComputerEquipment 2025-01-31 07500137 core:ComputerEquipment 2024-01-31 07500137 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-01-31 07500137 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-01-31 07500137 core:CostValuation core:Non-currentFinancialInstruments 2025-01-31 07500137 core:CostValuation core:Non-currentFinancialInstruments 2024-01-31 07500137 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-01-31 07500137 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 07500137 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-01-31 07500137 core:Non-currentFinancialInstruments 2025-01-31 07500137 core:Non-currentFinancialInstruments 2024-01-31 07500137 core:ShareCapital 2025-01-31 07500137 core:ShareCapital 2024-01-31 07500137 core:RetainedEarningsAccumulatedLosses 2025-01-31 07500137 core:RetainedEarningsAccumulatedLosses 2024-01-31 07500137 dpl:Item1 2024-02-01 07500137 dpl:Item1 2025-01-31 07500137 dpl:Item1 2023-02-01 07500137 dpl:Item1 2024-01-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 07500137
England and Wales

 

 

 

SYNERGY MEDICAL REPORTS LIMITED



Abridged Accounts
 


Period of accounts

Start date: 01 February 2024

End date: 31 January 2025
 
 
Notes
 
2025
£
  2024
£
Fixed assets      
Tangible fixed assets 3 23    1,563 
23    1,563 
Current assets      
Debtors 2,451    2,451 
Cash at bank and in hand 1,199    680 
3,650    3,131 
Creditors: amount falling due within one year (24,453)   (21,429)
Net current assets (20,803)   (18,298)
 
Total assets less current liabilities (20,780)   (16,735)
Creditors: amount falling due after more than one year (2,260)   (8,928)
Net assets (23,040)   (25,663)
 

Capital and reserves
     
Called up share capital 4 10    10 
Profit and loss account (23,050)   (25,673)
Shareholders' funds (23,040)   (25,663)
 


For the year ended 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006 the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the director on 08 April 2025 and were signed by:


-------------------------------
Sarah Tingling
Director
1
General Information
Synergy Medical Reports Limited is a private company, limited by shares, registered in England and Wales, registration number 07500137, registration address 201 Styal Road, Heald Green, Cheadle, Cheshire, SK8 3UA .
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Going concern basis
The directors believe that the company is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment 33% Straight Line
2.

Average number of employees

Average number of employees during the year was 1 (2024 : 1).
3.

Tangible fixed assets

Cost or valuation Computer Equipment   Total
  £   £
At 01 February 2024 4,665    4,665 
Additions  
Disposals  
At 31 January 2025 4,665    4,665 
Depreciation
At 01 February 2024 3,102    3,102 
Charge for year 1,540    1,540 
On disposals  
At 31 January 2025 4,642    4,642 
Net book values
Closing balance as at 31 January 2025 23    23 
Opening balance as at 01 February 2024 1,563    1,563 


4.

Share Capital

Authorised
10 Class A shares of £1.00 each
Allotted, called up and fully paid
2025
£
  2024
£
10 Class A shares of £1.00 each 10    10 
10    10 

2